link.springer.com

Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance - European Journal of Clinical Pharmacology

  • ️Richter, E.
  • ️Sat Mar 01 1975

References

  • Acocella, G., L. Bonollo, M. Garimoldi, M. Mainardi, T. Tenconi, F.B. Nicolis: Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease. Gut13, 47–53 (1972a)

    Google Scholar 

  • Acocella, G., A. Lamarina, F.B. Nicolis, V. Pagani, G. Segre: Kinetic studies on rifampicin. II. Multicompartmental analysis of the serum, urine and bile concentrations in subjects treated for one week. Europ. J. clin. Pharmacol.5, 111–115 (1972b)

    Google Scholar 

  • Boman, G.: Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid. Europ. J. clin. Pharmacol.7, 217–225 (1974)

    Google Scholar 

  • Bradley, S.E., F.J. Ingelfinger, G.P. Bradley: Hepatic circulation in cirrhosis of the liver. Circulation5, 419–429 (1952)

    Google Scholar 

  • Branch, A.R., G.D. Shand, G.R. Wilkinson, A.S. Nies: Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. J. clin. Invest.53, 1101–1107 (1974)

    Google Scholar 

  • Breimer, D.D.: Pharmacokinetics and biopharmaceutics of barbiturates and chloral hydrate in man. Ph.D.-thesis, Nijmegen, The Netherlands, (1974)

  • Breimer, D.D., J.M. van Rossum: Rapid and sensitive gas chromatographic determination of hexobarbital in plasma of man using a nitrogen detector. J. Chromatogr.88, 235–243 (1974)

    Google Scholar 

  • Breimer, D.D., C. Honhoff, W. Zilly, E. Richter, J.M. van Rossum: Pharmacokinetics of hexobarbital in man after intravenous infusion. J. Pharmacokin. Biopharm.3, 1–11 (1975)

    Google Scholar 

  • Bush, M.T., W.L. Weller: Metabolic fate of hexobarbital (HB). Drug Metab. Rev.1, 249–290 (1972)

    Google Scholar 

  • Bush, M.T., T.C. Butler, H.L. Dickison: The metabolic fate of 5(1 - cyclo-hexen-1-yl)-1,5-dimethyl barbituric acid (hexobarbital, Evipal) and of 5-(1-cyclo-hexen-1-yl)-5-methyl barbituric acid (“Nor-Evipal”). J. Pharmacol. exp. Ther.108, 104–111 (1953)

    Google Scholar 

  • Curci, G., N. Bergamini, F. Delli Veneri, A. Ninni, V. Nitti: Half-life of rifampicin after repeated administration of different doses in humans. Chemotherapia (Basel)17, 373–381 (1972)

    Google Scholar 

  • Edwards, O.M., R.J. Cortenay-Evans, J.M. Galley, J. Hunter, A.D. Tait: Changes in cortisol metabolism following rifampicin therapy. Lancet1974 II, 549–551

    Google Scholar 

  • Freij, H.H., F. Sudeney, D. Kranse: Vergleichende Untersuchungen über Stoffwechsel, Ausscheidung und Nachweis von Schlafmitteln aus der Barbitursäurereihe. Arzneimittel-Forsch.9, 294–297 (1959)

    Google Scholar 

  • Gillette, J.R.: Factors affecting drug metabolism. In: Drug metabolism in man. Ann. N.Y. Acad. Sci.179, 43–66 (1971)

    Google Scholar 

  • Hakim, J., G. Feldmann, J. Bucherot, P. Boivin, P. Guibout, B. Kreis: Effect of rifampicin, isoniazid and streptomycin on the human liver: a problem of enzyme induction. Gut12, 761 (1971)

    Google Scholar 

  • Held, H., R. Eisert, H.F. von Oldershausen: Pharmakokinetik von Glymidine (Glycodiazin) und Tolbutamid bei akuten und chronischen Leberschäden. Arzneimittel-Forsch. (Drug Res.)23, 1801–1807 (1973)

    Google Scholar 

  • Jezequel, A.M., F. Orlandi, L.T. Tenconi: Changes of the smooth endoplasmic reticulum induced by rifampicin in human and guineapig hepatocytes. Gut12, 984–987 (1971)

    Google Scholar 

  • Loo, J.C.K., S. Riegelman: Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion. J. pharm. Sci.59, 53–55 (1970)

    Google Scholar 

  • Maggi, N., S. Furesz, R. Pallanza, G. Pelizza: Rifampicin desacetylation in the human organism. Arzneimittel-Forsch.19, 651–654 (1969)

    Google Scholar 

  • Melikian, V., J.D. Eddy, A. Paton: The stimulant effect of drugs on indocyanine green clearance by the liver. Gut13, 755–758 (1972)

    Google Scholar 

  • Michot, F., M. Bürgi, J. Büttner: Rimactan (Rifampicin) und Antikoagulantientherapie. Schweiz. med. Wschr.100, 583–587 (1970)

    Google Scholar 

  • Nelson, E., J. O'Reilly, Th. Chulski: Determination of carboxytolbutamide in urine. Clin. chim. Acta5, 774–776 (1960)

    Google Scholar 

  • Nocke-Fink, L., H. Breuer, D. Reimers: Wirkung von Rifampicin auf den Menstruationszyklus und die Östrogenausscheidung bei Einnahme oraler Kontrazeptiva. Dtsch. med. Wschr.98, 1521–1523 (1973)

    Google Scholar 

  • Remmer, H., B. Schoene, R. Fleischmann, H. Held: Induction of the unspecific microsomal hydroxylase in the human liver. In: The liver. Quantitative aspects of structure and function. p. 232, Basel: Karger 1973

    Google Scholar 

  • Riegelman, S., M. Rowland: Effect of route of administration on drug disposition. J. Pharmacokin. Biopharm.1, 419–434 (1973)

    Google Scholar 

  • Rossum, J.M. van: Significance of pharmacokinetics for drug design and the planning of dosage regimes. In: Drug design, vol. I, pp. 469–521, New York: Academic Press, 1971

    Google Scholar 

  • Rowland, M., L.Z. Benet, G.G. Graham: Clearance concepts in pharmacokinetics. J. Pharmacokin. Biopharm.1, 123–136 (1973)

    Google Scholar 

  • Scheuer, P.J., S. Lal, J.A. Summerfield, S. Sherlock: Rifampicin hepatitis. Lancet1974 I, 421–425

    Google Scholar 

  • Schoene, B., R.A. Fleischmann, H. Remmer, H.F. von Oldershausen: Determination of drug metabolizing enzymes in needle biopsies of human liver. Europ. J. clin. Pharmacol.4, 65–73 (1973)

    Google Scholar 

  • Scholtan, W.: Die Bindung der Sulfonamide an Eiweißkörper. 6. Bestimmung der Eiweißbindung von Sulfonamiden mittels der Ultrazentrifuge und mittels Gelfiltration. Arzneimittel-Forsch.15, 1433–1441 (1965)

    Google Scholar 

  • Spingler, H.: Über eine Möglichkeit zur colorimetrischen Bestimmung von N-(4-Methyl-benzolsulfonyl)-N'-butyl-Harnstoff in Serum. Klin. Wschr.10, 533–535 (1957)

    Google Scholar 

  • Südhof, H., W. Eger, S. Altenburg, G. Schumacher: Blutzuckersenkung durch orale Antidiabetica und Verhalten des N-(4-Methyl-benzolsulfonyl)-N'-butyl-Harnstoffes im Serum in Abhängigkeit von der Leberfunktion. Arzneimittel-Forsch. (Drug Res.)7, 438–442 (1958)

    Google Scholar 

  • Thomas, R.C., G.J. Ikeda: The metabolic fate of tolbutamide in man and in the rat. J. med. Chem.9, 507–518 (1966)

    Google Scholar 

  • Thomson, P.D., K.L. Melman, J.A. Richardson, K. Cohn, W. Steinbrunn, R. Cudihee, M. Rowland: Lidocaine pharmacokinetics in advanced heart failure, liver disease and renal failure in humans. Ann int. Med.78, 499–508 (1973)

    Google Scholar 

  • Tsukamoto, H., S. Toki, K. Kaneda: Detection of hydroxyl derivatives from urine of men administered ethyl-hexabital and methyl-hexabital by buffered paper chromatography. Chem. pharm. Bull.6, 625–626 (1957)

    Google Scholar 

  • Virtanen, S., E. Tala: Serum concentration of rifampicin after oral administration. Clin. Pharmacol. Ther.16, 817–820 (1974)

    Google Scholar 

  • Zilly, W., D.D. Breimer, E. Richter: Unpublished investigation.

Download references